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Abstract 
We present a female patient with linear porokeratosis of her right arm since childhood. 
At the age of 67 years she additionally developed disseminated superficial actinic 
porokeratosis (DSAP) involving both lower legs. This uncommon coexistence of two 
different types of porokeratosis fulfils the clinical criteria of a type 2 segmental 
manifestation of an autosomal dominant skin disorder, being superimposed on the 
ordinary nonsegmental lesions and reflecting loss of heterozygosity that occurred at an 
early developmental stage. In DSAP molecular evidence of this concept is so far lacking, 
but such proof has already been provided in several other autosomal dominant skin 
disorders. Molecular analysis of cases of type 2 segmental involvement may help 
elucidate the genetic defect causing DSAP. 
 
Case Report 
A 61-year-old woman presented with linear lesions involving her right arm. The patient reported 
that the skin lesions – known since her childhood – changed during the past weeks. Especially lesions on 
her upper arm became erosive, increasingly red and pruritic (fig. 1a). Physical examination showed 
multiple bands consisting of reddish-brown, annular plaques with raised hyperkeratotic ridges and 
central atrophy. Neither other parts of the integument nor mucosal tissues were affected. Nail dystrophy 
or any other associated abnormalities were absent. Except for arterial hypertension there were no other 
diseases.  
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To confirm the clinical diagnosis and to exclude malignancy we performed two skin biopsies of the 
upper and lower right arm. Histopathological examination revealed typical cornoid lamella confirming 
the diagnosis of porokeratosis. The diagnosis of linear porokeratosis was made. Due to distressing 
cosmetic problems we started treatment with topical isotretinoin 0.1% cream once daily and skin care 
containing 5% urea. 
Six years later the patient presented with new skin lesions affecting both lower legs. Physical 
examination showed multiple, disseminated reddish-brown annular lesions with prominent 
hyperkeratotic ridges. These skin eruptions were smaller and less conspicuous than those of the right 
arm (fig. 1b). The histological examination demonstrated a porokeratosis, so that the clinical diagnosis 
of disseminated superficial actinic porokeratosis (DSAP) was confirmed. Parents and siblings were not 
affected. Only a minimal response was noted after 8-week treatment with imiquimod 5% cream.  
Discussion 
Porokeratosis is a group of genetic disorders characterized by a clonal proliferation of 
keratinocytes. Up to date, 6 different types have been identified. These include besides 
classic porokeratosis of Mibelli (PM), disseminated superficial actinic porokeratosis 
(DSAP), ‘linear porokeratosis’ (‘LP’), porokeratosis palmaris et plantaris disseminata 
(PPPD), disseminated superficial porokeratosis (DSP) and porokeratosis palmaris et 
plantaris punctata (PPPP). A distinctive histologic feature of all porokeratotic variants is 
the cornoid lamella which is characterized by a column of parakeratotic cells extending 
through the surrounding orthokeratotic stratum corneum, a decreased stratum 
granulosum beneath the parakeratotic column, dyskeratosis in the underlying stratum 
malpighii and a dermal perivascular lymphocytic infiltrate. 
The classic porokeratosis of Mibelli has a strong family history suggestive of autosomal 
dominant inheritance and can occur at every age. The multiple reddish-brown lesions 
with atrophic center mainly develop disseminated on the extremities, less often on the 
trunk or glans penis. So far, only one case of type 2 segmental porokeratosis of Mibelli 
was found in the literature [1]. By contrast, DSAP emerges after ultraviolet-exposure and 
therefore occurs in sun-exposed areas like the back of the hand, the forearms and lower 
legs and the face. DSAP is an autosomal dominant disorder. Its molecular basis is so far 
unknown, although three different genetic loci and diverse candidate genes have been 
proposed [2, 3]. However, these data could not be reproduced by other groups so far and 
require further confirmation [4, 5]. Except for sun exposure, several risk factors have been 
associated with the development of DSAP, including virus infection, immunosuppression 
and radioactivity. Linear porokeratosis usually arises in childhood and follows Blaschko’s 
lines.  
The coexistence of two different clinical forms of porokeratosis in a single individual is 
rare. To our knowledge, only 26 cases have been documented in the literature, so far. The 
most common combination is – as observed in the present patient – a linear 
porokeratosis combined with a DSAP. Linear porokeratosis is usually the first type of 
porokeratosis that is apparent in childhood, while DSAP appears later during the fourth 
and fifth decades of life. 
Following the concept by Happle, two types of segmental manifestation of an 
autosomal dominant skin disease can be distinguished. Type 1 reflects heterozygositiy for 
a new postzygotic mutation, as exemplified by a case of unilateral DSAP induced by 
immunosuppressive therapy of pemphigus vulgaris in a 68-year-old patient [6]. By 
contrast, type 2 results from loss of the corresponding wild-type allele occurring in a 
heterozygous embryo and reflects either homozygosity or hemizygosity for the underlying 
mutation, giving rise to rather pronounced segmental lesions that are superimposed on  
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the ordinary nonsegmental phenotype [7–9]. Recently, molecular proof of the theory of 
type 2 segmental manifestation has been provided in Hailey-Hailey disease [10], Cowden 
syndrome [11, 12] and Darier disease [13]. However, the concept of a type 2 segmental 
manifestation of an autosomal dominant skin disorder has been proposed for several 
other diseases and is awaiting further molecular proof (table 1). 
Following Happle’s theory, the present case of porokeratosis fulfills the criteria of a 
type 2 segmental manifestation of an autosomal dominant skin disorder [7]. This concept 
implies that a patient with DSAP carries a heterozygous germline mutation. Loss of the 
corresponding wild-type allele due to a somatic crossing-over or deletion may occur at an 
early developmental stage and give rise to a daughter cell representing a precursor of a 
clone which grows out in a linear pattern following the lines of Blaschko. This theory 
explains why the segmental lesions appear earlier in life and are more pronounced than 
the disseminated ones. The allelic loss may represent an initial stage in the process of 
carcinogenesis and may be responsible for the malignant potential being highest for the 
linear lesions [9]. 
In conclusion, our case highlights the importance of recognizing such uncommon 
segmental involvement being superimposed on the ordinary nonsegmental lesions. 
Molecular analysis of such cases may help elucidate the etiology of DSAP and corroborate 
the theory of type 2 segmental manifestation of this disorder. 
 
 
 
Table 1. Segmental type 2 manifestation of autosomal dominant skin diseases 
Skin disease  Molecular proof  Reference 
Hailey-Hailey disease  Provided   10 
Cowden syndrome  Provided  11, 12 
Darier disease  Provided  13 
DSAP  Needs to be confirmed  1 
Neurofibromatosis 1  Needs to be confirmed  14 
Epidermolytic hyperkeratosis of Brocq  Needs to be confirmed  15 
Cutaneous leiomyomatosis  Needs to be confirmed  16 
Acanthosis nigricans  Needs to be confirmed  17 
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Fig. 1. Type 2 segmental manifestation of disseminated superficial actinic porokeratosis: a pronounced 
linear lesions on the right arm present since birth; b less prominent disseminated lesions present on 
both lower legs since the age of 67 years. 
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